Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
6 pending office actions • 2 art units • 2 examiners • 0 of 6 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Gropro Corporation is currently managing 7 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are spread across 3 distinct examiners and 3 distinct art units, indicating a level of distribution in the company's prosecution efforts. The presence of 7 pending actions suggests an active phase of patent acquisition within the biotech sector.
EVANS, JASMINE AFIYA is the busiest examiner for the portfolio, holding 5 busiest examiner pending office actions. This concentration means that while there are 3 distinct examiners in total, this examiner is responsible for many of the 7 pending office actions. The fact that 3 distinct art units are involved shows that the 7 actions are not all confined to the same administrative group, even though the workload is heavily weighted toward this examiner. This distribution across 3 art units may reflect a range of pharmaceutical or biological technologies being pursued simultaneously.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 4 (67%) |
| Multi-statute (no §101) | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| EVANS, JASMINE AFIYA | 5 | — | — |
| KIM, DANIELLE A | 1 | 37.1% | +56.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18484686 | CHITOSAN ENCAPSULATION OF ABSOLUTE (ESSENTIAL) ROSEMARY, PEPPERMINT, AND COTTONSEED OILS | EVANS, JASMINE AFIYA | 141d overdue |
| 18433393 | CHITOSAN ENCAPSULATION OF ABSOLUTE (ESSENTIAL) ROSEMARY, PEPPERMINT, AND COTTONSEED OILS | KIM, DANIELLE A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18433393 | CHITOSAN ENCAPSULATION OF ABSOLUTE (ESSENTIAL) ROSEMARY, PEPPERMINT, AND COTTONSEED OILS | KIM, DANIELLE A | — |
| Art Unit | Apps |
|---|---|
| 1616 | 5 |
| 1613 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18433393 | CHITOSAN ENCAPSULATION OF ABSOLUTE (ESSENTIAL) ROSEMARY, PEPPERMINT, AND COTTONSEED OILS | KIM, DANIELLE A | 1613 | §103§112Other | Final Rejection | — | Pending | Feb 05, 2024 |
| 18484622 | CHITOSAN ENCAPSULATION OF ABSOLUTE (ESSENTIAL) GARLIC, CASTOR, LEMONGRASS, AND CEDARWOOD OIL | EVANS, JASMINE AFIYA | 1616 | §103§112DP | Non-Final OA | — | Pending | Oct 11, 2023 |
| 18484686 | CHITOSAN ENCAPSULATION OF ABSOLUTE (ESSENTIAL) ROSEMARY, PEPPERMINT, AND COTTONSEED OILS | EVANS, JASMINE AFIYA | 1616 | §103§112 | Non-Final OA | 141d overdue | Pending | Oct 11, 2023 |
| 18484648 | CHITOSAN ENCAPSULATION OF OXYMATRINE AND TEA SAPONIN FOR USE IN PESTICIDAL ACTIVITY | EVANS, JASMINE AFIYA | 1616 | §102§103§112DP | Non-Final OA | 126d overdue | Pending | Oct 11, 2023 |
| 18484603 | CHITOSAN ENCAPSULATION OF GERANIOL FOR USE IN PESTICIDAL ACTIVITY | EVANS, JASMINE AFIYA | 1616 | §102§103§112DP | Non-Final OA | — | Pending | Oct 11, 2023 |
| 18484427 | CHITOSAN ENCAPSULATION OF ABSOLUTE (ESSENTIAL) SPEARMINT, GARLIC, CLOVE, AND THYME OIL | EVANS, JASMINE AFIYA | 1616 | §103§112DP | Non-Final OA | — | Pending | Oct 10, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial